Finance

Senarai
SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
USD 7.34
0.00%
(0.00) 1H
26 Jun, 2:24:48 PTG GMT-4  ·   USD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk SHPMY...
Permodalan Pasaran
64.18B
Purata volum
267.00
Volum
16.00
tgi 52 mgu
USD 8.32
rdh 52 mgu
USD 7.07
Beta
0.59
Syer tertunggak
183.81J
Bilangan pekerja
50K
Permodalan Pasaran
64.18B
Purata volum
267.00
Volum
16.00
tgi 52 mgu
USD 8.32
rdh 52 mgu
USD 7.07
Beta
0.59
Syer tertunggak
183.81J
Bilangan pekerja
50K
Cerita berita
Daripada sumber merentas web
Profil
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Perihal Shanghai Pharmaceuticals Holdings ADR
CEO-
Pekerja49.6K
Diasaskan18 Jan 1994
Ibu pejabat-
Sektor-
Laman websphchina.com
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Penyata pendapatan
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Jun 2025
Sep 2025
Dis 2025
Mac 2026
Hasil
70.83B
73.48B
68.51B
75.26B
Kos barangan yang dijual
63.12B
66.03B
60.55B
67.17B
Kos hasil
63.12B
66.03B
60.55B
67.17B
Perbelanjaan penyelidikan dan pembangunan
461.93J
556.53J
824.53J
468.22J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
4.70B
4.70B
4.97B
4.59B
Belanja kendalian
5.44B
5.58B
5.91B
5.47B
Jumlah belanja kendalian
68.56B
71.60B
66.47B
72.63B
Pendapatan kendalian
2.27B
1.88B
2.04B
2.63B
Pendapatan bukan kendalian lain
-5.42J
-84.84J
-63.65J
-47.88J
EBT termasuk item luar biasa
4.67B
1.48B
1.52B
2.42B
EBT tidak termasuk item luar biasa
4.99B
1.61B
1.44B
2.27B
Belanja cukai pendapatan
1.31B
485.91J
534.14J
569.09J
Kadar cukai berkesan
28.14%
32.89%
35.10%
23.52%
Belanja kendalian lain
100.05J
129.62J
271.29J
132.16J
Pendapatan bersih
3.13B
688.20J
577.49J
1.42B
Margin untung bersih
4.41%
0.94%
0.84%
1.88%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
3.18B
206.57J
-
38.70J
Belanja faedah
-443.61J
-393.02J
-470.36J
-347.64J
Belanja faedah bersih
2.73B
-186.45J
-470.36J
-308.94J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
2.74B
2.26B
2.54B
3.12B
Keuntungan atau kerugian daripada jualan aset
-39.99J
39.99J
-157.15J
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian

Penyelidikan

Apakah perkara yang anda fikirkan?
Apakah yang berlaku dengan pasaran hari ini?
Terokai perkara yang boleh dilakukan
Buat portfolio
Buat tugasan
Deep Search
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian